Susquehanna International Group’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-11,000
| Closed | -$509K | – | 13281 |
|
|
2025
Q4 | $509K | Sell |
11,000
-1,200
| -10% | -$50.2K | ﹤0.01% | 8743 |
|
|
2025
Q3 | $427K | Buy |
12,200
+1,200
| +11% | +$41.7K | ﹤0.01% | 9327 |
|
|
2025
Q2 | $325K | Sell |
11,000
-1,900
| -15% | -$54.2K | ﹤0.01% | 10156 |
|
|
2025
Q1 | $385K | Buy |
+12,900
| New | +$394K | ﹤0.01% | 9487 |
|
|
2024
Q4 | – | Sell |
-23,200
| Closed | -$896K | – | 12317 |
|
|
2024
Q3 | $896K | Buy |
23,200
+3,900
| +20% | +$139K | ﹤0.01% | 7048 |
|
|
2024
Q2 | $621K | Sell |
19,300
-2,600
| -12% | -$90.2K | ﹤0.01% | 7742 |
|
|
2024
Q1 | $850K | Buy |
+21,900
| New | +$766K | ﹤0.01% | 7271 |
|
|
2023
Q1 | – | Sell |
-9,300
| Closed | -$216K | – | 12658 |
|
|
2022
Q4 | $216K | Buy |
+9,300
| New | +$188K | ﹤0.01% | 9947 |
|
|
2022
Q3 | – | Sell |
-20,800
| Closed | -$369K | – | 13273 |
|
|
2022
Q2 | $369K | Buy |
20,800
+5,000
| +32% | +$84.1K | ﹤0.01% | 8993 |
|
|
2022
Q1 | $322K | Buy |
+15,800
| New | +$299K | ﹤0.01% | 10100 |
|
|
2021
Q4 | – | Sell |
-15,700
| Closed | -$310K | – | 13182 |
|
|
2021
Q3 | $310K | Buy |
+15,700
| New | +$339K | ﹤0.01% | 10525 |
|
|
2021
Q2 | – | Sell |
-61,200
| Closed | -$1.45M | – | 12616 |
|
|
2021
Q1 | $1.45M | Sell |
61,200
-7,400
| -11% | -$176K | ﹤0.01% | 6732 |
|
|
2020
Q4 | $1.37M | Sell |
68,600
-9,900
| -13% | -$193K | ﹤0.01% | 5945 |
|
|
2020
Q3 | $1.63M | Buy |
+78,500
| New | +$1.42M | ﹤0.01% | 5002 |
|
|
2020
Q2 | – | Sell |
-51,100
| Closed | -$834K | – | 10199 |
|
|
2020
Q1 | $834K | Sell |
51,100
-7,500
| -13% | -$155K | ﹤0.01% | 5795 |
|
|
2019
Q4 | $1.21M | Buy |
58,600
+42,000
| +253% | +$700K | ﹤0.01% | 5163 |
|
|
2019
Q3 | $191K | Buy |
+16,600
| New | +$190K | ﹤0.01% | 9135 |
|
|
2019
Q2 | – | Sell |
-25,700
| Closed | -$389K | – | 10276 |
|
|
2019
Q1 | $389K | Sell |
25,700
-21,500
| -46% | -$344K | ﹤0.01% | 6747 |
|
|
2018
Q4 | $810K | Sell |
47,200
-36,600
| -44% | -$626K | ﹤0.01% | 5083 |
|
|
2018
Q3 | $1.24M | Buy |
83,800
+52,800
| +170% | +$936K | ﹤0.01% | 4823 |
|
|
2018
Q2 | $739K | Buy |
+31,000
| New | +$762K | ﹤0.01% | 6014 |
|
|
2018
Q1 | – | Sell |
-19,400
| Closed | -$358K | – | 9398 |
|
|
2017
Q4 | $358K | Buy |
+19,400
| New | +$278K | ﹤0.01% | 7271 |
|
|
2017
Q2 | – | Sell |
-40,800
| Closed | -$410K | – | 9249 |
|
|
2017
Q1 | $410K | Buy |
40,800
+26,100
| +178% | +$388K | ﹤0.01% | 6847 |
|
|
2016
Q4 | $229K | Buy |
+14,700
| New | +$244K | ﹤0.01% | 8453 |
|
Other funds holding COLL
EAM
VCM
Susquehanna International Group's COLL Position: Q1 2026 in Review
Susquehanna International Group increased its Collegium Pharmaceutical (COLL) stake by 274% in Q1 2026, buying an estimated $780K and bringing the position to 25,157 shares worth $832K. The position accounts for ﹤0.01% of the portfolio, ranked #8382.
Susquehanna International Group first reported a position in COLL in Q3 2015 and has held it in 25 quarters since. The position peaked at $1.87M in Q2 2018. 266 funds tracked by Wall St. Rank hold COLL as of Q1 2026.
- Susquehanna International Group held 25,157 shares of Collegium Pharmaceutical worth $832K as of Q1 2026.
- Susquehanna International Group bought 18,430 Collegium Pharmaceutical shares in Q1 2026, an estimated $780K.
- Collegium Pharmaceutical made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #8382 holding.
- Susquehanna International Group first reported a position in Collegium Pharmaceutical in Q3 2015 and has held it in 25 quarters since.
- Susquehanna International Group's Collegium Pharmaceutical position peaked at $1.87M in Q2 2018.
- 266 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2026.
Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.